Coherus Biosciences | CHRS - Ebit





Ebit 変化する 日付
AbbVie USD 6.88B 156M 2026-09
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Akebia Therapeutics USD -5.45M 9.4M 2025-12
ALKERMES USD 36.59M 102.52M 2026-09
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amarin USD -2.26M 564K 2025-12
Amgen USD 4.68B 65M 2026-09
Baxter International USD 314M 38M 2026-09
Biogen USD 419.5M 663.3M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Coherus Biosciences USD -39.08M 3.65M 2025-12
Eli Lilly USD 13.09B 635M 2026-09
Fujifilm JPY 89.98B 38.8B 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Merck USD 7.33B 6.49B 2026-09
Myriad Genetics USD -3M 20.3M 2025-12
Pacira USD 2.57B 2.56B 2026-09
Perrigo USD 27.2M 116.6M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
PTC Therapeutics USD 146.03M 100.14M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
Teva Pharmaceutical Industries USD 1.19B 954M 2026-09
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09
Xencor USD -36.6M 41.26M 2026-06
Zoetis USD 1.03B 88M 2026-09